Physician profile
Susie Xi-Feng Fong
NPI 1447549654
$8,500.39
in general payments reported to CMS, 2019-2025
9 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.08 · 2020: $22.37 · 2022: $2,293 · 2023: $3,928 · 2024: $1,441 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,771 · Food and Beverage: $2,085 · Travel and Lodging: $1,059 · Consulting Fee: $150 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,771.22 |
| Food and Beverage | $2,084.73 |
| Travel and Lodging | $1,058.70 |
| Consulting Fee | $150.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $4,754.54 | 2022-2024 | (8269) Dreamstation Cpap |
| Inspire Medical Systems, INC. | $2,857.90 | 2022-2025 | Inspire |
| Itamar Medical INC | $428.26 | 2023-2024 | Watchpatone |
| Jazz Pharmaceuticals INC. | $150.00 | 2025 | |
| Lilly USA, LLC | $120.67 | 2025 | Zepbound |
| Harmony Biosciences LLC | $99.99 | 2023 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $46.58 | 2025 | |
| Novo Nordisk INC | $22.37 | 2020 | |
| Insmed, INC. | $20.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susie Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.